Zoonotic relevance of multidrug-resistant bacteria in parrots with respiratory illness

Ahmed Samir1, Tarek Mosallam2, Hassan Aboul-Ella1

  • 1Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt.

Insights

Parrots can carry multidrug-resistant bacteria like E. coli and S. aureus in their noses, posing a zoonotic risk. This study identified these resistant bacteria in sick parrots, highlighting potential transmission to humans.

Area of Science:

  • Veterinary Microbiology
  • Zoonotic Diseases
  • Antimicrobial Resistance

Background:

  • Research often overlooks the nasal niche of parrots for bacterial pathogens.
  • Focus has shifted to cloacal investigations, leaving nasal carriage understudied.
  • Parrots can harbor bacteria with zoonotic potential, posing a public health concern.

Purpose of the Study:

  • To investigate nasal carriage of multidrug-resistant bacteria with zoonotic potential in parrots with respiratory illness.
  • To identify specific bacterial species and their resistance genes.
  • To assess the risk of parrots as reservoirs for zoonotic pathogens.

Main Methods:

  • Nasal swabs collected from 75 sick parrots with respiratory symptoms.
  • Microbiological isolation, identification, and antimicrobial susceptibility testing.
  • Molecular investigation for specific resistance genes (ESBL, mecA, vanA/vanB) and SCCmec typing.

Main Results:

  • Prevalence of Escherichia coli (36%), Klebsiella pneumoniae (32%), Proteus mirabilis (26.7%), and Staphylococcus aureus (9.3%) identified.
  • Detection of beta-lactamase genes (blaTEM, blaSHV, blaCTX-M-15) and the mecA gene in resistant isolates.
  • 67.1% of isolates showed multidrug resistance, with vanA gene found in Enterococcus faecalis.

Conclusions:

  • Parrots with respiratory illness can be carriers of multidrug-resistant zoonotic bacteria.
  • These findings indicate a potential role for parrots in transmitting resistant pathogens to humans.
  • Further research is needed to understand the transmission dynamics and mitigate risks.

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
188
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
267
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
122